Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

Cellebrite DI ( ($CLBT) ) just unveiled an announcement. On August 15, 2025, Cellebrite DI Ltd. announced its upcoming Annual General Meeting of ...

Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

For comparison, CLBT has a P/B of 11.34. These metrics, and several others, help SMGZY earn a Value grade of B, while CLBT has been given a Value grade of D. Both SMGZY and CLBT are impressive stocks ...

For comparison, CLBT has a P/B of 12.85. These are just a few of the metrics contributing to NU's Value grade of B and CLBT's Value grade of D. NU has seen stronger estimate revision activity and ...

In a remarkable display of market confidence, shares of CLBT have surged to an all-time high, touching a price level of $18.74. This milestone underscores the company's significant growth ...

Cellebrite DI (NASDAQ:CLBT) just reported results for the first quarter of 2024. Cellebrite DI reported earnings per share of 8 cents. This was above the analyst estimate for EPS of 5 cents. The ...

Both FUTU and CLBT are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that FUTU is the superior value option right now. Buy 5 Stocks BEFORE Election Day ...

In recent trading, shares of Cellebrite DI Ltd (Symbol: CLBT) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.74/share. When a stock reaches the ...